XRCC2 and central nervous system cancer: Furthermore, the results of the Cox analysis determined by the area under the receiver operating characteristic (ROC) curve (AUC) values suggested that XRCC2 is potentially useful for the prognostic assessment of glioma, especially for 5-year outcome (P > 0.7, Fig. 2E–G.